MP14-13 EVALUATING BASELINE AND CHANGE IN BODY COMPOSITION IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA WITH FRONT-LINE SYSTEMIC THERAPY: IMPLICATIONS FOR ADVERSE EVENTS AND OVERALL SURVIVAL

Authors :: Delaney Orcutt
Sofiane Mrah
Kaylee Oliva
Florian J. Fintelmann
J. Peter Marquardt
Scott S. Tykodi
John F. Thompson
Evan T. Hall
Joel Kramer
George R. Schade
Elliott Trott
Ryan B. O’Malley
Sarah P. Psutka
Yaw A. Nyame
John C. Gore
Maria M Wrobel
Evan Gross
Duncan Hussey
Dan Lin
Source :: Journal of Urology. 206
Publication Year :: 2021
Publisher :: Ovid Technologies (Wolters Kluwer Health), 2021.

Subjects :: Oncology
medicine.medical_specialty
business.industry
Urology
Front line
medicine.disease
Systemic therapy
Renal cell carcinoma
Internal medicine
Overall survival
Medicine
In patient
business
Adverse effect
Baseline (configuration management)

Full Text Access

Tools